Santen Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Santen Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Santen Pharmaceutical Co Ltd Strategy Report
- Understand Santen Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Santen Pharmaceutical Co Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Santen Pharmaceutical Co Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Akira Kurokawa
Chairman Executive BoardMr. Akira Kurokawa has been the Chairman of the company since 2020. Prior to this, he served in various roles within the company including as the President and Chief Executive Officer; the President and Chief Operating Officer; Head of Sales and Marketing Division, Prescription Pharmaceuticals, and also as Director and General Manager.
Takeshi Ito
Chief Executive Officer; Director; President Executive BoardMr. Takeshi Ito has been the President, Director and Chief Executive Officer of the company since 2022. Prior to this, he served as the Executive Vice President and Head of Japan Sales and Marketing Division, Head of Japan Business of the company.
Kazuo Koshiji
Chief Financial Officer; Chief Risk Officer Senior ManagementMr. Kazuo Koshiji has been the Chief Financial Officer, and Chief Risk Officer of the company since 2012. Prior to this, he has been the Chief Researcher/Consultant of MUFG Research & Consulting from 1997 to 2005; and led the business-development sections at Sumitomo Rubber Industries and Itoman Corporation
Rie Nakajima
Chief Operating Officer Senior ManagementMs. Rie Nakajima has been the Chief Operating Officer of the company since March 2023. Prior to this, she served as the Vice President, Strategy and Innovation Lead at Organon from 2021 to 2023. Previously she served in various leadership roles at MSD, BCG and Toyota Motor Corporation.
Nikolas Tripodis, Ph.D.
Chief Strategy Officer Senior ManagementDr. Nikolas Tripodis has been the Chief Strategy Officer of the company since March 2022. Prior to this, he has worked at Novartis AG in various leadership roles including, Head of Strategic Projects for Global Pharma from May 2021 to February 2022; Global Business Franchise Head of Ophthalmology from February 2019 to May 2021; Director of Corporate Strategic Planning; and General Manager in the Philippines and Russia. He has also worked for AstraZeneca as Marketing Head for Primary Care, Greece and for Boston Consulting Group.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer